Trial Profile
A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Stem cell therapies
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 21 Apr 2015 New trial record